Anixa Biosciences
ANIX
ANIX
44 hedge funds and large institutions have $15.8M invested in Anixa Biosciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 49 → 44 (-5)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
44
Holding in Top 10
–
Calls
$65K
Puts
$32K
Top Buyers
| 1 | +$364K | |
| 2 | +$266K | |
| 3 | +$133K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$86K |
| 5 |
VF
Virtu Financial
New York
|
+$79K |
Top Sellers
| 1 | -$201K | |
| 2 | -$156K | |
| 3 | -$115K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$96.5K |
| 5 |
CAM
Concorde Asset Management
Ann Arbor,
Michigan
|
-$65.9K |